Home/Filings/4/0001367644-22-000040
4//SEC Filing

Strei Katherine 4

Accession 0001367644-22-000040

CIK 0001367644other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 6:45 PM ET

Size

10.8 KB

Accession

0001367644-22-000040

Insider Transaction Report

Form 4
Period: 2022-02-28
Strei Katherine
EVP, Chief HR Officer
Transactions
  • Award

    Common Stock

    2022-03-01+24,16754,375 total
  • Award

    Common Stock

    2022-03-01+12,08366,458 total
  • Tax Payment

    Common Stock

    2022-02-28$39.64/sh561$22,23865,897 total
  • Award

    Employee Stock Options (Right to Buy)

    2022-03-01$41.38/sh+24,164$999,90624,164 total
    Exercise: $41.38Exp: 2029-02-28Common Stock (24,164 underlying)
Footnotes (4)
  • [F1]Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (6,042 shares) or on the day prior to the second anniversary date of the grant (18,125 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
  • [F2]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
  • [F3]Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.
  • [F4]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.

Issuer

Emergent BioSolutions Inc.

CIK 0001367644

Entity typeother

Related Parties

1
  • filerCIK 0001709639

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:45 PM ET
Size
10.8 KB